Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-28 @ 10:45 AM
Study NCT ID:
NCT07177404
Status:
RECRUITING
Last Update Posted:
2025-09-24
First Post:
2025-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes
Sponsor:
University of Nottingham
Organization:
Study Overview
Official Title:
Surveying Experiences and Lifestyle Effects in Choosing Technology and Hybrid Closed Loop in Type 1 Diabetes
Status:
RECRUITING
Status Verified Date:
2025-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SELECT HCL
Brief Summary:
Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper understanding of the perspective of people living with type 1 diabetes who have choices about which hybrid closed-loop systems fit their needs.
The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.
The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.
Detailed Description:
This is a cross-sectional online survey study, which involves people with type 1 diabetes who use closed-loop, wait to start closed-loop or considering closed-loop.
The primary objective of the study is to explore the factors driving the choices of people living with type 1 diabetes regarding closed-loop therapy.
The secondary objectives of the study are:
* To understand what treatment satisfaction with closed-loop therapy means to people living with type 1 diabetes
* To understand what additional support is needed for people with type 1 diabetes using closed-loop therapy
The primary objective of the study is to explore the factors driving the choices of people living with type 1 diabetes regarding closed-loop therapy.
The secondary objectives of the study are:
* To understand what treatment satisfaction with closed-loop therapy means to people living with type 1 diabetes
* To understand what additional support is needed for people with type 1 diabetes using closed-loop therapy
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: